MELISSA LANE: Open Payments
NPI 1336905850 · STROUDSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$434 in 21 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $868 · 2025 $434
Food & beverage: $434
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 6 | $158 |
| Teva Pharmaceuticals USA, Inc. | 5 | $93 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| Lundbeck LLC | 2 | $34 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: ARISTADA, REXULTI, AUSTEDO XR, TRINTELLIX, UZEDY, SPRAVATO, CAPLYTA, INGREZZA.
Industry payments across PA — which companies pay providers there.
